Advertisement

Canadian Anaesthetists’ Society Journal

, Volume 24, Issue 2, pp 243–251 | Cite as

The effects of repeated14C halothane exposure in mice

  • W. W. Stoyka
  • G. Havasi
Article

Keywords

Halothane Repeated Exposure Mitochondrial Pellet Chamber Concentration Halothane Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Cohen, E.N. &Hood, N. Application of low-temperature autoradiography to studies of the uptake and metabolism of volatile anaesthetics in the mouse III. Halothane. Anesthesiology31: 553–559 (1969).CrossRefGoogle Scholar
  2. 2.
    Van Dyke, R.A. &Wood, C.L. Binding of radioactivity from14C-labelled halothane in isolated perfused rat livers. Anesthesiology38: 328–332 (1973).PubMedGoogle Scholar
  3. 3.
    Cohen, E.N. Metabolism of Halothane-214C in the mouse. Anesthesiology31: 560–565 (1965).CrossRefGoogle Scholar
  4. 4.
    Topham, J.C. &Longshaw, S. Studies with halothane: I The distribution and excretion of halothane metabolites in animals. Anesthesiology37: 311–323 (1972).PubMedCrossRefGoogle Scholar
  5. 5.
    Stevens, W.C., Eger, E.I., White, A., Halsey, M.J., Munger, W., Gibbons, R.D., Dolan W. &Shargel R. Comparative toxicities of halothane, isoflurane, and diethyl ether at subanesthetic concentrations in laboratory animals. Anesthesiology42: 408–419 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    Sawyer, D.C., Eger, E.I., Bahlam, S.H., Cullen, B.F., &Impelman, A.B. Concentration dependence of hepatic halothane metabolism. Anesthesiology34: 230–235 (1971).PubMedCrossRefGoogle Scholar
  7. 7.
    Sedgwick, B. &Hubscher, G. Metabolism of phospholipids IX Phosphatidate phosphohy-drolase in rat liver, Biochima et Biophysica Acta106: 63–77 (1965).Google Scholar
  8. 8.
    Kamath, S.A. &Rubin, E. The exchange of phospholipids between subcellular organelles of the liver. Archives of Biochemistry and Biophysics158: 312–322 (1973).PubMedCrossRefGoogle Scholar
  9. 9.
    Takahashi, S., Shigematsu, A., &Furukawa, T. Interaction of volatile anaesthetics with rat microsomal cytochrome P-450. Anesthesiology41: 375–379 (1974).PubMedCrossRefGoogle Scholar
  10. 10.
    Ross, L.M. The cell. Ciba Clinical Symposia26: #3, I-35 (1974).Google Scholar
  11. 11.
    Cohen, E.N. &Trudell, J.R. Nonvolatile metabolites of halothane. Cellular biology and toxicity of anaesthetics. Edited by Fink, B.R. Baltimore: Williams and Wilkins, 205–214 (1972).Google Scholar
  12. 12.
    Rehder, K., Forbes, J., Alter, H., Hessler, C., &Stier, A. Halothane biotransformation in man: a quantitative study. Anesthesiology28: 711–715 (1967).PubMedCrossRefGoogle Scholar
  13. 13.
    Cascorbi, H.F., Blake, D.A., &Helrich, M. Differences in the biotransformation of halothane in man. Anesthesiology32: 119–123 (1970).PubMedCrossRefGoogle Scholar
  14. 14.
    Cohen, E.N., Trudell, J.R., Edmunds, H.N., &Watson, E. Urinary metabolites of halothane in man. Anesthesiology43: 392–401 (1975).PubMedCrossRefGoogle Scholar
  15. 15.
    Brown, B.R. Drugs, metabolism and toxicity. Audio digest Foundation. Anesthesiology18: 5 (March, 1976).Google Scholar
  16. 16.
    Inman, W.H.W. &Mushin, W.W. Jaundice after repeated exposure to halothane. An analysis of reports to the committee on the safety of medicines. Br. Med. J.1: 5–10 (1974).PubMedCrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 1977

Authors and Affiliations

  • W. W. Stoyka
    • 1
  • G. Havasi
    • 1
  1. 1.Department of AnaesthesiaUniversity of Toronto, St. Michael’s HospitalTorontoCanada

Personalised recommendations